Clinical Pharmacology of Factor XI Inhibitors: New Therapeutic Approaches for Prevention of Venous and Arterial Thrombotic Disorders

Bleeding is the dominant adverse event of anticoagulation and often discourages many patients and physicians from starting treatment with anticoagulant drugs. The fact that factor (F)XI deficiency is associated with a mild bleeding phenotype and that FXI knockdown or inhibition in different animal m...

Descripción completa

Detalles Bibliográficos
Autores principales: Campello, Elena, Simioni, Paolo, Prandoni, Paolo, Ferri, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654315/
https://www.ncbi.nlm.nih.gov/pubmed/36362541
http://dx.doi.org/10.3390/jcm11216314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654315/
https://www.ncbi.nlm.nih.gov/pubmed/36362541
http://dx.doi.org/10.3390/jcm11216314

Ejemplares similares